The drug efflux pump ABCB1 plays a key role in chemoresistance by effluxing various chemotherapeutic agents from tumor cells (21, 28, 29), and its expression is negatively correlated with the prognosis of cancers, including that of breast cancer (30, 31). Here, ABCB1 is linked to cancer.